Increased operational expenses and reduced cash reserves were cited. Roivant Sciences reports improved EPS for the second ...

With an estimated net worth of $800 million, Vivek Ramaswamy has accumulated wealth primarily through his significant stake ...

Trump made the announcement on social media, fulfilling a promise during the campaign to give Musk sweeping oversight of ...

Roivant Sciences Ltd (NASDAQ:ROIV) is set to release its Q2 2025 earnings on Nov 12, 2024. The consensus estimate for Q2 2025 ...

Trump appoints Elon Musk and Vivek Ramaswamy to lead the Department of Government Efficiency, aiming to cut bureaucracy and ...

Trump made the announcement on social media, fulfilling a promise during the campaign to give Musk sweeping oversight of ...

The S&P 500 Index ($SPX) (SPY) today is up +0.09%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.23%, and the Nasdaq ...

TD Cowen analyst Yaron Werber maintained a Buy rating on Roivant Sciences (ROIV – Research Report) today. The company’s shares ...

More recently, he has held consulting, advisory and investment partner roles with organisations including BIO, MIT, Roivant ...

Roivant Sciences Ltd. (ROIV) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.26 per share a year ago. These ...

The S&P 500 Index ($SPX) (SPY) today is down -0.13%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0. ...

BASEL, Switzerland - Roivant Sciences (NASDAQ:ROIV) announced the promising results of the Phase 1b ATMOS study for mosliciguat, a potential first-in-class inhaled therapy for... Roivant (Nasdaq ...